摘要腹膜透析作为安全有效的肾脏替代治疗方式之一,正在世界范围内尤其是亚洲国家得到广泛应用。同时,一些全国性透析登记数据,如2007年美国肾脏病数据系统（The United States Renal Data System，USRDS）的数据显示圆，腹膜透析治疗的患者生存率和技术生存率正在得到逐步提高。
1Lo WK.Peritoneal dialysis utilization and outcome:what are we facing?[J].Perit Dial Int,2007,27 Suppl 2:S42-47.
2Mehrotra R,Kermah D,Fried L,et al.Chronic peritoneal dialysis in the United States:declining utilization despite improving outcomes[J].J Am Soc Nephrol,2007,18:2781-2788.
3Adequacy of dialysis and nutrition in continuous peritoneal dialysis:association with clinical outcomes.Canada USA(CAN[JSA)Peritoneal Dialysis Study Group[J].J Am Soc Nephrol,1996,7:198-207.
4Churchill DN,Thorpe KE,Vonesh EF,et al.Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada.Canada-USA(CANUSA)Peritoneal Dialysis Study Group[J].J Am Soc Nephrol,1997,8:965-971.
5Churchill DN,Thorpe KE,Nolph KD,et al.Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients.The Canada-USA(CANUSA)Peritoneal Dialysis Study Group[J].J Am Soc Nephrol,1998,9:1285-1292.
6NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy.National Kidney Foundation[J].Am J Kidney Dis,1997,30:S67-136.
7Paniagua R,Amato D,Vonesh E,et al.Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis:ADEMEX,a prospective,randomized,controlled trial[J].J Am Soc Nephrol,2002,13:1307-1320.
8Lo WK,Ho YW,Li CS,et al.Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study[J].Kidney Int,2003,64:649-656.
9Lo WK,Bargman JM,Burkart J,et al.Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis[J].Perit Dial Int.2006,26:520-522.
10Dombros N,Dratwa M,Feriani M,et al.European best practice guidelines for peritoneal dialysis.7 Adequacy of peritoneal dialysis[J].Nephrol Dial Transplant,2005,20 Suppl 9:ⅸ24-ⅸ27.
